• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$20.20 $0.08 (0.40%)

REAL-TIME: Last trade at

Warner Chilcott Ltd.

NASDAQ:WCRX

Jump to this page for:

Related Resources

Warner Chilcott drops 2% as strategic review process continues

5/24/2012 by Theflyonthewall.com

WCRX, Watson Pharma in Legal Tussle - Analyst Blog

5/23/2012 by Zacks Investment Research

WCRX, Watson Pharma in Legal Tussle

5/23/2012 by Zacks Equity Research Analyst Blog

Warner Chilcott, PLC Sues Watson Pharmaceuticals, Inc. Over Generic Contraceptive

5/18/2012 by BioSpace

Warner Chilcott Sues Watson Over Generic Contraceptive

5/17/2012 by Bloomberg.com

Warner Chilcott volatility elevated during strategic review

5/14/2012 by Theflyonthewall.com

Warner Chilcott Profit Hits $113M

5/7/2012 by Drug Discovery & Development

Warner Chilcott Tops But Cuts View - Analyst Blog

5/7/2012 by Zacks Investment Research

Warner Chilcott Tops But Cuts View

5/7/2012 by Zacks Equity Research Analyst Blog

Needham & Company Maintains a 'Hold' on Warner Chilcott (WCRX); Valuation Paradox

5/7/2012 by StreetInsider.com

Cost-Cutting Boosts Warner Chilcott's First-Quarter Earnings

5/5/2012 by Morningstar

Warner Chilcott turns 1Q profit as costs fall

5/4/2012 by Bioscience Technology

Warner Chilcott's CEO Discusses Q1 2012 Results - Earnings Call Transcript

5/4/2012 by Seeking Alpha

Warner Chilcott swings to profit as expenses fall

5/4/2012 by MarketWatch

Warner Chilcott raises 2012 adjusted EPS view to $3.60-$3.70, consensus $3.65

5/4/2012 by Theflyonthewall.com

Warner Chilcott updating guidance ranges for 2012 total revenue, Net income

5/4/2012 by Theflyonthewall.com

Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2012

5/4/2012 by StockWatch

Warner Chilcott plc (WCRX) Reports Q1 Adj-EPS of $1.16

5/4/2012 by StreetInsider.com

Earnings Watch For May 4 (AES, DUK, EXC, WCRX)

5/4/2012 by RTTNews

Trading Radar for 05/04: Novavax (NVAX), Federal Signal (FSS), Arcos Dorados (ARCO), U.S. Cellular (USM), Warner Chilcott (WCRX) Report

5/3/2012 by StreetInsider.com

Critical Alerts For American International, Wynn, Barrick Gold, Fluor, and Warner Chilcott Released By InvestorsObserver

5/3/2012 by StockWatch

The Costs Of Being Obese (PFE, AZN, WLP, CI, WCRX)

5/2/2012 by Investopedia

Warner Chilcott Luring Drug Buyers With Most Free Cash: Real M&A

5/2/2012 by Bloomberg.com

First Doryx generic is released by Mylan

5/1/2012 by Chain Drug Review

How Bayer Could Benefit From Potential Warner Chilcott Buyout

5/1/2012 by iStockAnalyst

Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official

5/1/2012 by StreetInsider.com

Announcement Under Irish Takeover Rules Relevant Securities in Issue

5/1/2012 by GlobeNewswire

Goldman to host a conference

5/1/2012 by Theflyonthewall.com

Mylan, Impax Win Ruling in Patent Case With Warner-Chilcott Over Doryx

4/30/2012 by Bloomberg.com

Warner Chilcott Confirms Strategic…

4/30/2012 by FOX - Fox 5 - Washington DC

Warner Chilcott (WCRX) Says Generic Doryx Doesn't Violate '161 Patent, Sees FY12 Impairment Charge of $90-$108M

4/30/2012 by StreetInsider.com

Warner Chilcott Announces Decision in Doryx Patent Litigation

4/30/2012 by GlobeNewswire

Needham remains skptical of a high premium take-out bid for Warner Chilcott

4/30/2012 by Theflyonthewall.com

Market Movers: AAPL & WCRX

4/30/2012 by CNBC Video

Gen-Probe deal boosts Hologic

4/30/2012 by FT.com

Warner Chilcott, Monster Beverage…

4/30/2012 by FOX - Fox 5 - Washington DC

Warner Chilcott, Monster Beverage Among Stocks Up on High Volume Monday

4/30/2012 by FOXBusiness.com

Warner Chilcott in Talks Over Takeover

4/30/2012 by The Wall Street Journal

Canaccord Genuity Maintains a 'Buy' on Warner Chilcott (WCRX); Taking A Closer Look

4/30/2012 by StreetInsider.com

Top Stock Alerts for Day Traders: Allscripts, Chesapeake Energy, Expedia, Western Digital, Arena Pharmaceuticals, and Warner Chilcott

4/30/2012 by PR Newswire
See More Articles...